BioCanvas
표적 · GLRX2

GLRX2 항체

1최다 인용
25인용된 항체
12벤더
Antibody Registry데이터 출처 · RRID CC0

논문 인용순 항체

Antibody Registry 인용수 기준 · 25종
1
Thermo Fisher Scientific#PA5-115290 RRID:AB_2899926 polyclonal
1
cited by
2
Abnova#H00051022-B02P RRID:AB_1673997 polyclonal
0
cited by
3
Abnova#H00051022-M03 RRID:AB_1674838 monoclonal
0
cited by
4
Atlas Antibodies#HPA023087 RRID:AB_1849778 polyclonal
0
cited by
5
abcepta#AP7301b RRID:AB_1967743 monoclonal
0
cited by
6
Syd Labs#PA000525-E-MA0021 RRID:AB_2110365 monoclonal
0
cited by
8
Thermo Fisher Scientific#PA5-14187 RRID:AB_2294613 polyclonal
0
cited by
9
LSBio (LifeSpan)#LS-C100887 RRID:AB_2294614 polyclonal
0
cited by
10
Creative Diagnostics#CABT-26770MH RRID:AB_2346516 monoclonal
0
cited by
11
Creative Diagnostics#CPBT-35516RH RRID:AB_2369547 unknown
0
cited by
12
Creative Diagnostics#DPABH-06413 RRID:AB_2509735 unknown
0
cited by
13
Thermo Fisher Scientific#PA5-44837 RRID:AB_2577031 polyclonal
0
cited by
14
Thermo Fisher Scientific#PA5-54692 RRID:AB_2642041 polyclonal
0
cited by
15
Thermo Fisher Scientific#PA5-66066 RRID:AB_2664913 polyclonal
0
cited by
16
Atlas Antibodies#HPA057224 RRID:AB_2683373 polyclonal
0
cited by
17
ABclonal#A6603 RRID:AB_2767194 polyclonal
0
cited by
18
Thermo Fisher Scientific#PA5-93087 RRID:AB_2806616 polyclonal
0
cited by
19
Affinity Biosciences#DF12618 RRID:AB_2845580 unknown
0
cited by
20
Boster Biological Technology#A05331 RRID:AB_3081691 polyclonal
0
cited by
21
Boster Biological Technology#PA1885 RRID:AB_3082822 polyclonal
0
cited by
22
LSBio (LifeSpan)#LS-C100887-100 RRID:AB_10558767 polyclonal
0
cited by
23
Proteintech#13381-1-AP RRID:AB_10643373 polyclonal
0
cited by
24
Aviva Systems Biology#ARP57792_P050 RRID:AB_10714502 polyclonal
0
cited by
25
abcepta#AP12642b RRID:AB_10818280 monoclonal
0
cited by
이 표적 항체를 국내 공급가·납기로 확인하시겠어요? 국내 구매·견적 문의 →

GLRX2

이 표적에 논문에서 가장 많이 인용된 항체 순으로 정리했습니다. 각 행에서 국내 견적을 요청할 수 있습니다.

Data: Antibody Registry (SciCrunch) — RRID under CC-0; product metadata per respective source. Citation counts: Antibody Registry.